Pregnant women's exercise self-efficacy.
Conditions
Interventions
Intervention 1: Intervention group participants will receive an 8-week gamified intervention program consisting of weekly sessions that integrate evidence-based prenatal exercises and postural correct
Sponsors
Gonabad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Iranian nationality Willingness to participate in the study Age range: 18-45 years No medical restrictions for performing pregnancy exercises, as confirmed by a gynecologist Literacy ability to read and write Gestational age: 20 to 28 weeks No medical conditions (e.g., diabetes, hypertension, mental disorders or cardiovascular/respiratory diseases) No high-risk pregnancy conditions (e.g., bleeding in the current pregnancy, placenta previa, cervical cerclage, multiple pregnancies or pregnancies achieved through assisted reproductive techniques) No substance addiction
Exclusion criteria
Exclusion criteria: Significant comorbidities (e.g., uncontrolled cardiovascular/metabolic diseases) History of adverse obstetric outcomes (e.g., preterm delivery, recurrent pregnancy loss, or active antenatal bleeding) Medical contraindications to physical activity per specialist evaluation (e.g., placenta previa, cervical insufficiency, or high-risk preterm labor) Current regular structured exercise programs (>2 sessions/week) Use of medications affecting exercise capacity (e.g., beta-blockers, corticosteroids) Non-compliance (refusal to sign informed consent or protocol deviation) Substance use disorder (active illicit drug/alcohol abuse)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean score of pregnant women's exercise self-efficacy. Timepoint: Before the intervention, immediately after the intervention, and at 1- and 2-week follow-ups. Method of measurement: Pregnant Women's Exercise Self-Efficacy Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of low back and pelvic pain. Timepoint: Before the intervention, immediately after the intervention, and at 1- and 2-week follow-ups. Method of measurement: visual analog scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactTahereh Tavasoli
Gonabad University of Medical Sciences
Outcome results
None listed